Abstract
PB1320 A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MG1113 in Healthy Subjects and Hemophilia Patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have